DEVELOPMENT AND VALIDATION OF PROGNOSTIC MODELS FOR MYOCARDIAL INFARCTION, STROKE AND CARDIOVASCULAR DEATH AND HOSPITALISED BLEEDING IN STABLE MYOCARDIAL INFARCTION SURVIVORS

The risk of recurrent cardiovascular (CV) events and bleeding remains high in stable myocardial infarction (MI) survivors in the US, England, Sweden and France [Rapsomaniki 2014]. However there are no prognostic models to support risk stratification of this population. The study aim was to develop